Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for prevention of postoperative cognitive dysfunction after major elective non-cardiac surgery
ACTRN12614000411640Phase 2Recruiting
- Sponsor
- University Hospital Geelong
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-operative cognitive decline (POCD) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Severity of early postoperative cognitive dysfunction. Started Apr 2015; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ACTRN12614000411640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000411640.